Twitter | Search | |
Search Refresh
JAMA Oncology Feb 16
With 30 different randomized clinical trials of systemic therapy for tumors (), this meta-analysis compares efficacy & tolerability to provide broad conclusions in absence of trials directly comparing leading options.
Reply Retweet Like
Simon buckley Jan 25
Good news from hospital stable cancer
Reply Retweet Like
Carlos Miguel Ruiz Mar 12
Hi tweeples! How would you call this liver mtx of NE neoplasm?? Previous history: Large cell NE Cx of lung And what is your ki-67?
Reply Retweet Like
Ricky Kalmon May 28
Reply Retweet Like
Aatur Singhi, MD PhD Jan 14
SharkCore Biopsy of a Poorly-differentiated Carcinoma (PanNEC), Large Cell Type. High Ki-67 and frequent Rb loss. An aggressive
Reply Retweet Like
Stefano Partelli Feb 14
Local treatments of liver mets allow patients affected by tumors with focal progression to continue existing systemic therapy. . @endohttps://erc.bioscientifica.com/view/journals/erc/26/4/ERC-18-0462.xml#.XGWMmu_k19M
Reply Retweet Like
Matthew Zaborowski Sep 26
Distal pancreatectomy, showing typical features of a pancreatic neuroendocrine tumour (grade 2 in this case). Most Pan-NETs are sporadic, but ~10-20% are associated with inherited tumor syndromes including MEN1, VHL, NF1, TSC, and others.
Reply Retweet Like
Thomas Clancy Oct 24
Last OR day of fantastic sabbatical here with professor Peter Stalberg, head of neuroendocrine unit in Uppsala Sweeden
Reply Retweet Like
Aatur Singhi, MD PhD Apr 1
Clear Cell Variant of Pancreatic Tumor () that is often associated with genomic alterations in VHL. Tumor cells are filled with cytoplasmic clear vesicles. May mimic a metastatic Renal Cell Carcinoma.
Reply Retweet Like
Duilio Rocha Filho Mar 7
TALENT ph 2 trial (N=111), lenvatinib 24 mg/day in progressive, pretreated NET pts: ORR 40% in pNET, 18% in GI-NET. Median PFS ~15 mo in both groups. Exciting data.
Reply Retweet Like
Héctor Enrique Mar 13
Charly, take a look at this paper... The family name is: .
Reply Retweet Like
Erin Leibowitz Aug 25
Created a young adult FB group for those diagnosed with cancer before age 45. Search it or message me if you're interested in joining!
Reply Retweet Like
Julie Hallet MD MSc Jan 23
Great news today - now funded to examine symptoms burden and outcomes for tumors! Thanks for the support and mentorship getting there. Very excited to get this work going with researchers and patient partners. ⚫️⚪️⚫️
Reply Retweet Like
Markey Cancer Center Dec 2
“Finding new treatments and cures is what really gets me going.” – Dr. Aman Chauhan, specialist at Markey.
Reply Retweet Like
Zachary Fattal Sep 10
When you encounter a carotid body mass, it is always worth thinking about a paraganglioma! These are characterized by small nests of clear cells (CD56, synaptophysin, and chromogranin positive) surrounded by sustentacular cells (S100 positive)!
Reply Retweet Like
Alastair MacDonald May 6
Our review on in systems is online now . Give it a read here if you're interested:
Reply Retweet Like
Stefania Landolfi May 16
Reply Retweet Like
Endocrine Surgery Jan 27
Reply Retweet Like
Advanced Accelerator Applications Mar 7
Talking tumors with the experts at in Barcelona
Reply Retweet Like
Int J Endocrine Onc Jun 24
Our Assistant Editor will be attending the symposium on treatment-emergent prostate cancer at the tomorrow with . Get in touch if you will also be there, it would be great to meet!
Reply Retweet Like